Essential Medical, Inc., is a privately held company focused on transforming the large bore vascular closure market by delivering products that meet the unmet need for closure without complications. The company has developed two products, MANTA and X-Seal. X-Seal is the company’s CE Marked vascular closure device with superior handling and closure features. X-Seal closes femoral arterial punctures made during cardiac catheterization procedures such as angiograms, angioplasty, and stenting. X-Seal is designed to provide Cath Lab professionals with superior closure and improved hemostasis. MANTA is a novel vascular closure device designed to close punctures ranging from 10F to 24F at femoral arterial access sites after cardiac catheterization procedures such as transcatheter aortic valve replacement (TAVR), endovascular treatment of abdominal aortic aneurysms (AAA), ventricular assist (VAD), and balloon aortic valvuloplasty (BAV). These procedures are the fastest growing segment of the cardiovascular market. Closure of large bore femoral access sites has been associated with significant morbidity including long times to achieve hemostasis, extended procedure time, need for a vascular surgeon in the catheterization lab, delayed ambulation, higher rate of complications and higher total cost of care. MANTA was designed to address the complexities of closing large punctures in high-pressure vessels utilizing novel closure technology. MANTA’s fail-safe deployment provides immediate hemostasis in order to reduce complications associated with large bore closure. Visit www.essmedclosure.com to learn more.